50,000 heart patients enrolled in Real-World stent study

NCT ID NCT01788592

Recruiting now Disease control Sponsor: Seung-Jung Park Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is tracking 50,000 people with coronary artery disease who receive drug-eluting stents during a routine procedure to open blocked heart arteries. Researchers want to see how well these stents prevent major heart problems like death, heart attack, or the need for another procedure. The goal is to understand how these stents perform in everyday practice, not just in controlled trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: drug-eluting stent
What this could lead to: If successful, this study could confirm that drug-eluting stents are safe and effective for routine use in a broad range of patients with coronary artery disease.
What could go wrong: This is an observational study, not a randomized trial, so results may be influenced by patient selection. It does not test a new treatment, only evaluates existing practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE

Contacts and locations

Locations

Asan Medical Center
RECRUITING

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.